RIOK1_HUMAN - dbPTM
RIOK1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RIOK1_HUMAN
UniProt AC Q9BRS2
Protein Name Serine/threonine-protein kinase RIO1
Gene Name RIOK1 {ECO:0000312|HGNC:HGNC:18656}
Organism Homo sapiens (Human).
Sequence Length 568
Subcellular Localization Cytoplasm, cytosol .
Protein Description Involved in the final steps of cytoplasmic maturation of the 40S ribosomal subunit. Involved in processing of 18S-E pre-rRNA to the mature 18S rRNA. Required for the recycling of NOB1 and PNO1 from the late 40S precursor. [PubMed: 22072790 The association with the very late 40S subunit intermediate may involve a translation-like checkpoint point cycle preceeding the binding to the 60S ribosomal subunit (By similarity Despite the protein kinase domain is proposed to act predominantly as an ATPase (By similarity The catalytic activity regulates its dynamic association with the 40S subunit (By similarity In addition to its role in ribosomal biogenesis acts as an adapter protein by recruiting NCL/nucleolin the to PRMT5 complex for its symmetrical methylation]
Protein Sequence MDYRRLLMSRVVPGQFDDADSSDSENRDLKTVKEKDDILFEDLQDNVNENGEGEIEDEEEEGYDDDDDDWDWDEGVGKLAKGYVWNGGSNPQANRQTSDSSSAKMSTPADKVLRKFENKINLDKLNVTDSVINKVTEKSRQKEADMYRIKDKADRATVEQVLDPRTRMILFKMLTRGIITEINGCISTGKEANVYHASTANGESRAIKIYKTSILVFKDRDKYVSGEFRFRHGYCKGNPRKMVKTWAEKEMRNLIRLNTAEIPCPEPIMLRSHVLVMSFIGKDDMPAPLLKNVQLSESKARELYLQVIQYMRRMYQDARLVHADLSEFNMLYHGGGVYIIDVSQSVEHDHPHALEFLRKDCANVNDFFMRHSVAVMTVRELFEFVTDPSITHENMDAYLSKAMEIASQRTKEERSSQDHVDEEVFKRAYIPRTLNEVKNYERDMDIIMKLKEEDMAMNAQQDNILYQTVTGLKKDLSGVQKVPALLENQVEERTCSDSEDIGSSECSDTDSEEQGDHARPKKHTTDPDIDKKERKKMVKEAQREKRKNKIPKHVKKRKEKTAKTKKGK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
21PhosphorylationGQFDDADSSDSENRD
CCCCCCCCCCCCCCC
37.4529255136
22PhosphorylationQFDDADSSDSENRDL
CCCCCCCCCCCCCCH
45.7819664994
24PhosphorylationDDADSSDSENRDLKT
CCCCCCCCCCCCHHH
38.4229255136
30UbiquitinationDSENRDLKTVKEKDD
CCCCCCHHHHHHHCC
56.4132015554
31PhosphorylationSENRDLKTVKEKDDI
CCCCCHHHHHHHCCC
44.0728111955
38UbiquitinationTVKEKDDILFEDLQD
HHHHHCCCCHHHHHH
7.3324816145
78UbiquitinationDWDEGVGKLAKGYVW
CCCCCCHHHCCEEEC
42.7522817900
81UbiquitinationEGVGKLAKGYVWNGG
CCCHHHCCEEECCCC
62.3021890473
81UbiquitinationEGVGKLAKGYVWNGG
CCCHHHCCEEECCCC
62.3021890473
83PhosphorylationVGKLAKGYVWNGGSN
CHHHCCEEECCCCCC
11.11-
89PhosphorylationGYVWNGGSNPQANRQ
EEECCCCCCCCCCCC
46.8925159151
90UbiquitinationYVWNGGSNPQANRQT
EECCCCCCCCCCCCC
35.6622817900
93UbiquitinationNGGSNPQANRQTSDS
CCCCCCCCCCCCCCC
17.9021890473
95MethylationGSNPQANRQTSDSSS
CCCCCCCCCCCCCCC
44.14115491277
97PhosphorylationNPQANRQTSDSSSAK
CCCCCCCCCCCCCCC
31.1220363803
98PhosphorylationPQANRQTSDSSSAKM
CCCCCCCCCCCCCCC
27.4420363803
100PhosphorylationANRQTSDSSSAKMST
CCCCCCCCCCCCCCC
26.4220363803
101PhosphorylationNRQTSDSSSAKMSTP
CCCCCCCCCCCCCCH
39.0320363803
102PhosphorylationRQTSDSSSAKMSTPA
CCCCCCCCCCCCCHH
35.54-
104UbiquitinationTSDSSSAKMSTPADK
CCCCCCCCCCCHHHH
35.0224816145
106PhosphorylationDSSSAKMSTPADKVL
CCCCCCCCCHHHHHH
30.4524719451
107PhosphorylationSSSAKMSTPADKVLR
CCCCCCCCHHHHHHH
20.9928985074
111AcetylationKMSTPADKVLRKFEN
CCCCHHHHHHHHHHH
45.3225953088
116UbiquitinationADKVLRKFENKINLD
HHHHHHHHHHCCCHH
11.4824816145
124UbiquitinationENKINLDKLNVTDSV
HHCCCHHHCCCCHHH
45.1629967540
128PhosphorylationNLDKLNVTDSVINKV
CHHHCCCCHHHHHHH
22.8328555341
130PhosphorylationDKLNVTDSVINKVTE
HHCCCCHHHHHHHCH
18.6124961811
134UbiquitinationVTDSVINKVTEKSRQ
CCHHHHHHHCHHHHH
39.1332015554
142UbiquitinationVTEKSRQKEADMYRI
HCHHHHHHHCHHHHC
54.4824816145
154UbiquitinationYRIKDKADRATVEQV
HHCCCHHHHHHHHHH
46.6324816145
166PhosphorylationEQVLDPRTRMILFKM
HHHCCHHHHHHHHHH
29.9422210691
175PhosphorylationMILFKMLTRGIITEI
HHHHHHHHHHHHHEE
24.2922210691
180PhosphorylationMLTRGIITEINGCIS
HHHHHHHHEECCCCC
28.9728122231
187PhosphorylationTEINGCISTGKEANV
HEECCCCCCCCCEEE
34.8728122231
188PhosphorylationEINGCISTGKEANVY
EECCCCCCCCCEEEE
32.1528122231
195PhosphorylationTGKEANVYHASTANG
CCCCEEEEEEECCCC
7.4725072903
198PhosphorylationEANVYHASTANGESR
CEEEEEEECCCCCCC
18.1025072903
199PhosphorylationANVYHASTANGESRA
EEEEEEECCCCCCCE
25.5625072903
204PhosphorylationASTANGESRAIKIYK
EECCCCCCCEEEEEE
28.5425072903
218UbiquitinationKTSILVFKDRDKYVS
EEEEEEECCCCCCCC
44.36-
223PhosphorylationVFKDRDKYVSGEFRF
EECCCCCCCCCEEEE
12.2527642862
225PhosphorylationKDRDKYVSGEFRFRH
CCCCCCCCCEEEECC
29.5223186163
245PhosphorylationNPRKMVKTWAEKEMR
CHHHHHHHHHHHHHH
20.6329666759
291UbiquitinationDMPAPLLKNVQLSES
CCCHHHHHHHCCCHH
63.8624816145
295UbiquitinationPLLKNVQLSESKARE
HHHHHHCCCHHHHHH
5.5124816145
299UbiquitinationNVQLSESKARELYLQ
HHCCCHHHHHHHHHH
47.62-
327UbiquitinationLVHADLSEFNMLYHG
HHCCCHHHCCCEEEC
48.6224816145
334UbiquitinationEFNMLYHGGGVYIID
HCCCEEECCEEEEEE
22.4632015554
369SulfoxidationANVNDFFMRHSVAVM
CCCHHHHHHHHHHHH
3.6821406390
410PhosphorylationMEIASQRTKEERSSQ
HHHHHHHCHHHHHCC
34.8623312004
411MethylationEIASQRTKEERSSQD
HHHHHHCHHHHHCCC
60.82-
415PhosphorylationQRTKEERSSQDHVDE
HHCHHHHHCCCCCCH
35.3130108239
416PhosphorylationRTKEERSSQDHVDEE
HCHHHHHCCCCCCHH
45.9430108239
426UbiquitinationHVDEEVFKRAYIPRT
CCCHHHHHHHHCCCC
41.0929967540
426MethylationHVDEEVFKRAYIPRT
CCCHHHHHHHHCCCC
41.09115976697
428UbiquitinationDEEVFKRAYIPRTLN
CHHHHHHHHCCCCHH
13.7524816145
432UbiquitinationFKRAYIPRTLNEVKN
HHHHHCCCCHHHHHC
42.1424816145
438UbiquitinationPRTLNEVKNYERDMD
CCCHHHHHCHHHHHH
47.8632015554
440PhosphorylationTLNEVKNYERDMDII
CHHHHHCHHHHHHHH
13.46-
451UbiquitinationMDIIMKLKEEDMAMN
HHHHHHHCHHHHHHH
54.2429967540
464UbiquitinationMNAQQDNILYQTVTG
HHHHHHCHHHHHHHC
5.2224816145
466PhosphorylationAQQDNILYQTVTGLK
HHHHCHHHHHHHCCH
9.8021945579
468PhosphorylationQDNILYQTVTGLKKD
HHCHHHHHHHCCHHC
13.3821945579
470PhosphorylationNILYQTVTGLKKDLS
CHHHHHHHCCHHCCC
39.9429978859
473UbiquitinationYQTVTGLKKDLSGVQ
HHHHHCCHHCCCCCC
45.6529967540
474UbiquitinationQTVTGLKKDLSGVQK
HHHHCCHHCCCCCCC
69.7929967540
481UbiquitinationKDLSGVQKVPALLEN
HCCCCCCCHHHHHHH
48.0229967540
494PhosphorylationENQVEERTCSDSEDI
HHHCCCCCCCCCCCC
21.46-
503PhosphorylationSDSEDIGSSECSDTD
CCCCCCCCCCCCCCC
24.2524461736
504PhosphorylationDSEDIGSSECSDTDS
CCCCCCCCCCCCCCC
37.0924461736
507PhosphorylationDIGSSECSDTDSEEQ
CCCCCCCCCCCCCCC
39.2224461736
509PhosphorylationGSSECSDTDSEEQGD
CCCCCCCCCCCCCCC
25.7324461736
511PhosphorylationSECSDTDSEEQGDHA
CCCCCCCCCCCCCCC
45.1624461736
525PhosphorylationARPKKHTTDPDIDKK
CCCCCCCCCCCCCHH
45.3028985074
532UbiquitinationTDPDIDKKERKKMVK
CCCCCCHHHHHHHHH
60.0324816145
536UbiquitinationIDKKERKKMVKEAQR
CCHHHHHHHHHHHHH
55.9624816145
539UbiquitinationKERKKMVKEAQREKR
HHHHHHHHHHHHHHH
43.7829967540
544UbiquitinationMVKEAQREKRKNKIP
HHHHHHHHHHHCCCC
45.1724816145
548UbiquitinationAQREKRKNKIPKHVK
HHHHHHHCCCCHHHH
52.0724816145
568UbiquitinationTAKTKKGK-------
HCCCCCCC-------
67.0824816145
580Ubiquitination-------------------
-------------------
24816145

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
410TPhosphorylationKinaseCSNK2A1P68400
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RIOK1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RIOK1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
ANM5_HUMANPRMT5physical
25852190
MEP50_HUMANWDR77physical
25852190
U520_HUMANSNRNP200physical
27173435
SMU1_HUMANSMU1physical
27173435
U5S1_HUMANEFTUD2physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RIOK1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-22, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-22, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-22 AND SER-24,AND MASS SPECTROMETRY.

TOP